May 17, 2016 / 8:27 PM / a year ago

BRIEF-Valeant considering disposal of Obagi Medical Products as well as Provenge - Bloomberg

1 Min Read

May 17 (Reuters) -

* Valeant Pharmaceuticals considering disposal Of Obagi Medical Products Inc, dermatology company it acquired in 2013, as well as Provenge - Bloomberg

* Valeant Pharmaceuticals may sell drugs acquired from Marathon Pharmaceuticals last year - Bloomberg citing source

* Valeant Pharmaceuticals divestitures could raise as much as $1 billion and attract other drugmakers with an interest in those areas - Bloomberg Source: (bloom.bg/1WBHJIN) Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below